SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Esperion Therapeutics, Inc. & Advises Invest...
January 14 2016 - 7:48PM
Business Wire
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it
is investigating claims of potential misrepresentations by Esperion
Therapeutics, Inc. (“Esperion” or the “Company”) (Nasdaq: ESPR).
The investigation focuses on whether the Company and its officers
violated securities laws by issuing misleading information to
investors.
If you purchased or otherwise acquired Esperion shares and would
like more information regarding the investigation, we advise you to
contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650
Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The investigation will focus on whether the Company issued
materially false and misleading statements to investors and/or
failed to disclose that there was no clear path to approval for
ETC-1002. The FDA had encouraged Esperion Therapeutics to initiate
a cardiovascular outcomes trial (“CVOT”) and completion of a CVOT
could be necessary prior to approval of ETC-1002.
If you have any questions concerning your legal rights in this
case, please immediately contact Goldberg Law PC at 800-977-7401,
or visit our website at http://www.Goldberglawpc.com, or email us
at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160114006478/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.comhttps://twitter.com/search?q=goldberglawpc&src=typdhttps://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024